Folate Receptor Alpha Autoantibodies in Vector-Borne Disease Populations
Diseases · 05.06.2026 · 14 (6) · 202
DOI: 10.3390/diseases14060202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases, online erschienen am 05.06.2026. Verfasst von Lindsey Wells und 3 weiteren Autor:innen. Beteiligte Einrichtung: Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vector-borne diseases (VBDs) caused by Borrelia spp., Bartonella spp., and Babesia spp. are associated with neuropsychiatric morbidity. Cerebral folate deficiency (CFD), primarily caused by folate receptor-α autoantibodies (FRAAs) impairing folate blood–brain barrier transport, is a treatable contributor to neurodevelopmental disorders including pediatric acute-onset neuropsychiatric syndrome (PANS) and autism spectrum disorder. Despite overlapping clinical manifestations, FRAA prevalence in VBD populations has not been investigated. This study aimed to determine the prevalence of FRAA in patients with confirmed VBDs.
Methods
This retrospective cohort study included 68 VBD-positive patients with and without PANS evaluated at a single clinical practice. VBD testing was performed by IGeneX Laboratories; FRAA analysis including binding, blocking, and soluble folate receptor (sFR) testing was performed by Religen Laboratories (Plymouth Meeting, PA). Statistical associations were assessed using Fisher’s exact test with Wilson 95% confidence intervals.
Results
Of the 68 VBD-positive patients, 42 (61.8%; 95% CI: 49.9–72.4%) were also FRAA-positive. Soluble folate receptor (sFR) was detected in eight patients (11.8%; 95% CI: 6.1–21.5%), all of whom were binding FRAA-positive, with 87.5% carrying confirmed evidence of Borrelia species infection. Neuropsychiatric symptoms were highly prevalent across both groups but did not significantly differentiate FRAA-positive from FRAA-negative patients (all p > 0.05).
Conclusions
This study demonstrates a high prevalence of FRAA in a pediatric VBD cohort. The sFR was strongly associated with Borrelia species infection, suggesting a potential mechanistic link between spirochetal infection and folate receptor autoimmunity. These findings support the consideration of FRAA testing in patients with VBDs and warrant further investigation in larger prospective cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA.
ORCID-Profile: Richard E Frye
Zitieren
APA
Wells, L., Hinchey, M., Frye, R. E., & Morgan, A. (2026). Folate Receptor Alpha Autoantibodies in Vector-Borne Disease Populations. Diseases, 14(6), 202. https://doi.org/10.3390/diseases14060202
Vancouver
Wells L, Hinchey M, Frye RE, Morgan A. Folate Receptor Alpha Autoantibodies in Vector-Borne Disease Populations. Diseases. 2026;14(6):202. doi:10.3390/diseases14060202
BibTeX
@article{Wells2026,
author = {Wells, Lindsey and Hinchey, Myriah and Frye, Richard E and Morgan, Amelia},
title = {Folate Receptor Alpha Autoantibodies in Vector-Borne Disease Populations},
journal = {Diseases},
year = {2026},
volume = {14},
number = {6},
pages = {202},
doi = {10.3390/diseases14060202}
}
EUVIMED